Features Martina Ravelli T’18, one of Poets & Quants’ 100 MBAs to watch from the class of 2018. Ravelli, who graduated with highest distinction this spring and joined Microsoft after earning her MBA, says that Tuck offered the kind of experience she was looking for from business school.
Features insights from Vijay Govindarajan in an article about how companies can embrace disruption.
Highlights Tuck as one of the top business schools for preparing students to be leaders on a global stage.
Mentions research by Eugene Fama and Kenneth French in an opinion piece regarding the performance of factor investing in 2018.
On “Bloomberg Markets: America,” Peter Fisher discusses the Federal Reserve’s impact on both ends of the yield curve and why the bank must stop its practice of forward guidance.
Highlights Tuck's new admissions criteria, which will evaluate candidates using four separate attributes—smart, nice, accomplished, and aware, and mentions reaction from industry consultants.
Quotes Luke Anthony Peña in a feature story about Tuck’s new admissions criteria, which will evaluate candidates based on four attributes—smart, nice, accomplished, and aware.
Quotes Richard D’Aveni in an article about jet engine manufacturer Pratt & Whitney’s attempts to increase its efficiency.
Quotes Quentin Reeve T’13 and Nicolas Fiore T’17 in an article about the sixth annual Global Tuck ‘Tails, which will bring together current students and alumni at events around the world throughout July.
As a guest on Bloomberg Television, Roger Lynch T’95, CEO of Pandora, discusses the future of the music streaming platform, including a new partnership with Snap and a push into podcasts.
Names Tuck in an article about the Financial Times’ recent ranking of the top MBA programs around the world for entrepreneurship, in which Tuck was ranked #3.
A feature story about The Skeww, a website started by T’18s Sean Graber and Keal Harter, which takes the day’s trending political news and, using machine learning and language processing, aligns what media outlets are reporting on a political spectrum from left to right.
Vijay Govindarajan discusses the new health care venture from Amazon, JP Morgan, and Berkshire Hathaway, including why Atul Gawande is the right choice to lead the project.
Dean Matthew J. Slaughter discusses new trade policies, including tariffs, and their impact on the economy of New Hampshire and the United States as a whole on New Hampshire Public Radio’s “The Exchange.”
As a guest on Bloomberg Markets, Vijay Govindarajan and Ravi Ramamurti discuss their new book Reverse Innovation in Health Care.
Vijay Govindarajan and coauthor Ravi Ramamurti write that the U.S. could revamp its health care system and lower the cost of care delivery by exploring innovative ideas first implemented in India.
In an interview with MarketWatch, Vijay Govindarajan and Ravi Ramamurti discuss their new book, Reverse Innovation in Health Care: How to Make Value-Based Delivery Care Work.
Vijay Govindarajan and coauthor Mahesh Sriram illustrate how the United States health care system can learn from Indian innovations, using three examples of entrepreneurs that delivered high-value care at low-costs.
Quotes Luke Anthony Peña in a feature story about Tuck’s new admissions criteria, which will evaluate candidates based on four attributes—smart, nice, accomplished, and aware.
Cites research by Eugene Fama and Kenneth French in an article about whether investors should consider value stocks during a bear market.
Quotes Davin Chor in an article about the Trump administration’s decision to levy tariffs in response to what it deems unfair global trade practices against the United States.
Quotes Vijay Govindarajan in an article about how Indian health care innovators are setting an example the United States should follow as it seeks to improve its health care system.
Mentions Tuck’s Next Step: Transition to Business program designed for military veterans and elite athletes in an article about how professional athletes should prepare for their retirements—first from sport and later from their careers.
Vijay Govindarajan and Ravi Ramamurti discuss their new book, Reverse Innovation in Health Care: How to Make Value-Based Delivery Work.
Quotes Dean Matthew J. Slaughter in an article about the impact new tariffs on China will have on smaller U.S. businesses, such as Cree, a North Carolina-based maker of lighting products.
Quotes Dean Matthew J. Slaughter in an article about how recently proposed policies could have adverse effects on industries such as farming, automotive, and energy.
Features Jarett Berke T’17, who recently purchased a Hanover landmark institution, Lou’s Restaurant and Bakery.
Vijay Govindarajan and coauthor Jie Gan explore how China has built itself into a hub of innovation, and what the transformation could mean for the future.
Vijay Govindarajan discusses his forthcoming book Reverse Innovation in Health Care, which explores how the U.S. can improve its health care system with innovations first implemented in places like India.
Mentions the three-factor model developed in the 1990s by Eugene Fama and Kenneth French in an article about the rise of smart beta investing and how retail investors can use the practice to their advantage.
Profiles Fred McKinney, managing director of minority business programs, whose career path has spanned academia, government, and industry.
Richard D’Aveni explores recent advances in 3D printing, also known as additive manufacturing, and offers a playbook on how the technology can shape business models and strategy decisions.
Vijay Govindarajan and coauthor Ravi Ramamurti explain how bottom-up innovation is driving change in the U.S. health care system.
Cites research by Dean Matthew J. Slaughter in an article about the impact global trade uncertainty has on supply chains.
Quotes Dean Matthew J. Slaughter in an article about Harley-Davidson’s decision to move a portion of production outside the United States.
Vijay Govindarajan and coauthor Ravi Ramamurti illustrate how reverse innovation allowed Health City Cayman Islands (HCCI) to provide low-cost, value-based care and why the U.S. health care industry should take note.